---
figid: PMC6117394__fonc-08-00333-g0004
figlink: /pmc/articles/PMC6117394/figure/F4/
number: Figure 4
caption: Biochemical mechanisms of oncometabolite accumulation. Inactivating mutations
  in genes encoding succinate dehydrogenase (SDH) and fumarate hydratase (FH), as
  well as oncogenic mutations in isocytrate dehydrogenase (IDH), lead to the accumulation
  of succinate, fumarate and D-2-hydroxyglutarate (D-2-HG). These oncometabolites
  inhibit α-KG-dependent dioxygenases, including prolyl hydroxylases (PHDs), the ten-eleven
  translocation (TET) family of methylcytosine hydroxylases and histone lysine demethylases
  (KDMs), leading to HIF1α stabilization and alterations in gene expression through
  epigenetic modifications. Separately, fumarate inactivates by succination both aconitase
  2 (ACO2) and Kelch-like ECH associated protein 1 (KEAP1), which results in the activation
  of the antioxidant pathway mediated by NRF2, and also generates succinated glutathione
  (GSF), an alternative substrate to glutathione reductase (GSR). Additionally, tumor
  cells can use alternative ways to increase oncometabolite concentration, such as
  the upregulation of the mitochondrial chaperone TRAP1, which inhibits the activity
  of SDH, leading to the intracellular accumulation of succinate. 2SC, succination
  of cysteine residues; EMT, epithelial-to-mesenchymal transition; GSH, reduced glutathione;
  HO-1, heme oxygenase-1; IMS, intermembrane space, M, methylation; OAA, oxaloacetate;
  P, phosphorylation, Succ-CoA, succinyl-CoA; U, ubiquitination.
pmcid: PMC6117394
papertitle: Metabolic Plasticity of Tumor Cell Mitochondria.
reftext: Giuseppe Cannino, et al. Front Oncol. 2018;8:333.
pmc_ranked_result_index: '201688'
pathway_score: 0.9490373
filename: fonc-08-00333-g0004.jpg
figtitle: Biochemical mechanisms of oncometabolite accumulation
year: '2018'
organisms: Homo sapiens
ndex: 6251b967-def8-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6117394__fonc-08-00333-g0004.html
  '@type': Dataset
  description: Biochemical mechanisms of oncometabolite accumulation. Inactivating
    mutations in genes encoding succinate dehydrogenase (SDH) and fumarate hydratase
    (FH), as well as oncogenic mutations in isocytrate dehydrogenase (IDH), lead to
    the accumulation of succinate, fumarate and D-2-hydroxyglutarate (D-2-HG). These
    oncometabolites inhibit α-KG-dependent dioxygenases, including prolyl hydroxylases
    (PHDs), the ten-eleven translocation (TET) family of methylcytosine hydroxylases
    and histone lysine demethylases (KDMs), leading to HIF1α stabilization and alterations
    in gene expression through epigenetic modifications. Separately, fumarate inactivates
    by succination both aconitase 2 (ACO2) and Kelch-like ECH associated protein 1
    (KEAP1), which results in the activation of the antioxidant pathway mediated by
    NRF2, and also generates succinated glutathione (GSF), an alternative substrate
    to glutathione reductase (GSR). Additionally, tumor cells can use alternative
    ways to increase oncometabolite concentration, such as the upregulation of the
    mitochondrial chaperone TRAP1, which inhibits the activity of SDH, leading to
    the intracellular accumulation of succinate. 2SC, succination of cysteine residues;
    EMT, epithelial-to-mesenchymal transition; GSH, reduced glutathione; HO-1, heme
    oxygenase-1; IMS, intermembrane space, M, methylation; OAA, oxaloacetate; P, phosphorylation,
    Succ-CoA, succinyl-CoA; U, ubiquitination.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATP5MPL
  - MT-ATP6
  - VEGFD
  - MT-ATP8
  - PGF
  - VEGFA
  - WDTC1
  - GSR
  - HMOX1
  - IDH1
  - SDHB
  - KEAP1
  - VEGFB
  - ATP4B
  - IDH2
  - ATP5IF1
  - FH
  - VEGFC
  - ATP5F1E
  - ACO2
  - MAPK3
  - SRC
  - MAPK1
  - ZEB1
  - Succinate
  - Glutamine
  - Glutamate
  - O-KG
  - Succinate Fumarate
  - TRAPI
  - FAD
  - NADH
  - NAD
  - ADP
  - ATP
  - Bilirubin
  - KG
  - TCA
  - Cysteine
  - Isocitrate
  - Glycine
  - Acetyl-CoA
  - Citrate
  - GSH
  - NADPH
  - NADP
genes:
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: ATP5MPL
  entrez: '9556'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: MT-ATP6
  entrez: '4508'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: MT-ATP8
  entrez: '4509'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: ADP
  symbol: ADP
  source: hgnc_alias_symbol
  hgnc_symbol: WDTC1
  entrez: '23038'
- word: GSR
  symbol: GSR
  source: hgnc_symbol
  hgnc_symbol: GSR
  entrez: '2936'
- word: (HO-1)
  symbol: HO-1
  source: hgnc_alias_symbol
  hgnc_symbol: HMOX1
  entrez: '3162'
- word: IDH1
  symbol: IDH1
  source: hgnc_symbol
  hgnc_symbol: IDH1
  entrez: '3417'
- word: SDH
  symbol: SDH
  source: hgnc_prev_symbol
  hgnc_symbol: SDHB
  entrez: '6390'
- word: KEAP1
  symbol: KEAP1
  source: hgnc_symbol
  hgnc_symbol: KEAP1
  entrez: '9817'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: ATP4B
  entrez: '496'
- word: IDH2)
  symbol: IDH2
  source: hgnc_symbol
  hgnc_symbol: IDH2
  entrez: '3418'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: ATP5IF1
  entrez: '93974'
- word: FH
  symbol: FH
  source: hgnc_symbol
  hgnc_symbol: FH
  entrez: '2271'
- word: VEGF
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: ATPsynthase
  symbol: ATP_synthase
  source: bioentities_symbol
  hgnc_symbol: ATP5F1E
  entrez: '514'
- word: ACO2
  symbol: ACO2
  source: hgnc_symbol
  hgnc_symbol: ACO2
  entrez: '50'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: (c-Src
  symbol: c-src
  source: hgnc_alias_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: ZEB1
  symbol: ZEB1
  source: hgnc_symbol
  hgnc_symbol: ZEB1
  entrez: '6935'
chemicals:
- word: Succinate
  source: MESH
  identifier: D013386
- word: Glutamine
  source: MESH
  identifier: C578860
- word: Glutamate
  source: ''
  identifier: ''
- word: O-KG
  source: MESH
  identifier: D020410
- word: Succinate Fumarate
  source: MESH
  identifier: D005650
- word: TRAPI
  source: ''
  identifier: ''
- word: FAD
  source: MESH
  identifier: D005182
- word: NADH
  source: MESH
  identifier: D009243
- word: NAD
  source: MESH
  identifier: D009243
- word: ADP
  source: MESH
  identifier: D000244
- word: ATP
  source: MESH
  identifier: D000255
- word: Bilirubin
  source: MESH
  identifier: D001663
- word: KG
  source: MESH
  identifier: D020410
- word: TCA
  source: MESH
  identifier: C000589078
- word: Cysteine
  source: MESH
  identifier: D003545
- word: Isocitrate
  source: MESH
  identifier: D007523
- word: Glycine
  source: MESH
  identifier: D005998
- word: Acetyl-CoA
  source: MESH
  identifier: D000105
- word: Citrate
  source: MESH
  identifier: C102006
- word: GSH
  source: MESH
  identifier: D005978
- word: NADPH
  source: MESH
  identifier: D009249
- word: NADP
  source: MESH
  identifier: D009249
diseases: []
---
